Active substances
Fusidic acid + Hydrocortisone
- SFDA 2
- Health Canada 1
- NHS prices 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| FUCIDIN H CREAM | 20,10 mg,mg | Cream · Topical | 1 Tube | SAR 38.50 | NCE · Prescription | Leo Pharma | Valid |
| FUCIDIN H CREAM | 20,10 mg,mg | Cream · Topical | 1 Tube | SAR 19.25 | NCE · Prescription | Leo Pharma | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ECZEMA; GRAFT VERSUS HOST DISEASE
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| FUCIDIN H | 02238578 | 2 %; 1 % | CREAM · TOPICAL | LEO PHARMA INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Hydrocortisone acetate 1% / Fusidic acid 2% cream | £6.02 | 30 gram | 1 Oct 2026 |
| NHS Drug Tariff | Hydrocortisone acetate 1% / Fusidic acid 2% cream | £12.05 | 60 gram | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.